Skip to content

Stylized cells, blue

Category: Genomics


How to Improve Your RNA-Seq Data with UMIs and ERCC RNA

Quantifying transcripts accurately and reproducibly is critical when studying gene expression. Scientists have developed two powerful tools for RNA sequencing (RNA-Seq) experiments to minimize bias and variability: unique molecular identifiers (UMIs) and ERCC RNA spike-ins. We’ll cover the basics of each and how they can help you produce better RNA-Seq data. Unique Molecular Identifiers (UMIs) What are […]

Troubleshooting DNA Templates with Sanger Sequencing

Sanger sequencing is highly effective for testing small targeted genomic regions and for validating results from NGS. However, as with all sequencing technologies, there are limitations and needs for troubleshooting. Sanger Sequencing Troubleshooting If the sample that you are sequencing does not produce the desired read quality, we recommend starting with three basic troubleshooting steps. […]

Ensure Complete Plasmid Validation on Your First Attempt with Oxford Nanopore Sequencing

In the current sequencing landscape, there are two major technologies that are often used to read the nucleotide bases in plasmid DNA: the traditional Sanger method and long-read sequencing using Oxford Nanopore Technology (ONT). These two methods have a few fundamental differences and work best when used synergistically for an accurate and comprehensive view into […]

The Power of Proteomics

The landscape of drug development is constantly evolving, fueled by groundbreaking scientific advancements. While genetics has played a central role in understanding diseases, proteomics – the study of proteins – provides a more comprehensive picture of disease phenotypes and mechanisms. Proteins act as intermediate phenotypes, bridging the gap between genetic associations and tangible disease pathology. […]

Circular RNA: An Emerging Frontier in RNA Therapeutics

Circular RNA (circRNA), a covalently closed single-stranded RNA molecule, has rapidly gained traction in the research and discovery setting. Initially considered a result of erroneous RNA splicing since the mid-1970’s, circRNAs have subsequently demonstrated a role in a wide array of biological functions. These functions include transcriptional/translational regulators, microRNA sponges, protein scaffolds, and encoding small […]

The Brewer’s Genomic Toolbox for Better Beer

Brewing beer is a complex process that requires careful control of its parameters, including the yeast strains used for fermentation. Brewer’s yeast (Saccharomyces cerevisiae) not only generates ethanol and carbon dioxide, but also creates flavors and aromas in beer. For example, ale yeast tends to produce fruity, spicy, or floral flavors and aromas, whereas lager […]

Comparing Mass Spectrometry, ELISA, and Olink for Proteomics

The field of proteomics has evolved significantly in the last decade, with several technologies now available to assay protein biomarkers in clinical studies. In this article, we compare three popular approaches for proteomics – mass spectrometry, ELISA, and the Olink® Proximity Extension Assay (PEA) – and highlight their strengths and limitations. Mass Spectrometry Assays based on mass spectrometry […]

Biobanking Quality Management Systems and Best Practices

Part Two of our Protecting Complete Chain of Custody Series As we discussed in our last post, the Role of Biobanking in Protecting Sample Chain of Custody, biobanks serve as biospecimen libraries as well as sample data, validation, and reference sources for both research and clinical labs. Like any part of a controlled process, establishment of a quality […]

Role of Biobanking in Protecting Sample Chain of Custody

Part One of our Protecting Complete Chain of Custody Series As key components of the research ecosystem, biobanks share a vital function and critical responsibility in the protection of biospecimens. They are centralized members in the chain of custody for samples, and as such, have an impact on both upstream and downstream portions of the molecular biologist’s […]

Fine-Tuning mRNA Structure for Better mRNA Therapies

The structure of mRNA has been known for decades, but only in recent years have researchers unlocked its potential for therapeutic development. With the right delivery vehicle, mRNA products can replace defective proteins in the cell, generate antigens for immunization (e.g., COVID vaccines), or edit the genome via CRISPR technology. Let’s review the structural features of a […]